Labcorp
1,060 hedge funds and large institutions have $22.2B invested in Labcorp in 2026 Q2 according to their latest regulatory filings, with 106 funds opening new positions, 361 increasing their positions, 398 reducing their positions, and 75 closing their positions.
41% more first-time investments, than exits
New positions opened: 106 | Existing positions closed: 75
7% more capital invested
Capital invested by funds: $20.9B → $22.2B (+$1.36B)
6% more funds holding in top 10
Funds holding in top 10: 16 → 17 (+1)
2% more funds holding
Funds holding: 1,037 → 1,060 (+23)
1.85% more ownership
Funds ownership: 94.99% → 96.84% (+1.8%)
9% less repeat investments, than reductions
Existing positions increased: 361 | Existing positions reduced: 398
31% less call options, than puts
Call options by funds: $41.2M | Put options by funds: $59.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$180M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$162M |
| 3 |
Amundi
Paris,
France
|
+$84.8M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$55.3M |
| 5 |
EARNEST Partners
Atlanta,
Georgia
|
+$43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$121M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$99.7M |
| 3 |
JP Morgan Chase
New York
|
-$69.5M |
| 4 |
MIM
Meridiem Investment Management
London,
United Kingdom
|
-$52M |
| 5 |
Select Equity Group
New York
|
-$50.7M |
LH Hedge Fund Activity: Q2 2026 in Review
1,060 of the 8,348 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2026, worth a combined $22.2B — up 6.5% from $20.9B a quarter earlier.
Buyers outnumbered sellers: 106 funds opened new LH positions and 75 closed out — a net gain of 31 holders — while 361 added to existing stakes and 398 trimmed.
The largest buyer was Boston Partners, adding an estimated $180M. The largest seller was AllianceBernstein, cutting an estimated $121M.
- 1,060 institutional investors held Labcorp (LH) as of Q2 2026, up from 1,037 in Q1 2026.
- Funds reported $22.2B of Labcorp stock for Q2 2026, up 6.5% quarter-over-quarter.
- 106 funds opened new Labcorp positions in Q2 2026 and 75 closed out, a net change of +31 holders.
- The largest Labcorp buyer in Q2 2026 was Boston Partners, an estimated $180M added.
- The largest Labcorp seller in Q2 2026 was AllianceBernstein, an estimated $121M sold.
Based on aggregated 13F filings for Q2 2026.